IMR Press / EJGO / Volume 24 / Issue 3-4 / pii/2003161

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Pelvic relapses in ovarian cancer. Role of CA-125, transvaginal ultrasound and color Doppler

Show Less
1 Department of Experimental Medicine, University of L' Aquila, Italy
Eur. J. Gynaecol. Oncol. 2003, 24(3-4), 269–270;
Published: 10 June 2003

From January 1995 to January 2001, 40 patients with epithelial ovarian cancer were treated at our Institution. Fourteen of these, with a clinical CR after surgery and platinum-based chemotherapy, were evaluated monthly by gynecological examination, Ca-125 RIA assay, pelvic ultrasound with transabdominal and transvaginal probe and color Doppler Six pelvic relapses, from 1.5 to 3.0 cm, were detected by transvaginal ultrasound (US). They showed a rich neovascularization with low resistance, high flow, PI from 0.3 to 1.0 and RI < 0.5 in all cases. US did not reveal any sign of relapse in the remaining eight patients. In all cases of pelvic relapses ultrasonic signs of recurrence preceded the increase of Ca-125 by one to six months (average 3.8).

Ovarian Cancer
Pelvic relapse
Transvaginal ultrasound
Back to top